Advances in Cancer Biology - Metastasis : Impact Factor & More
eISSN: 2667-3940
Open AccessShare this on:
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Advances in Cancer Biology - Metastasis Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
DOAJ 
SJR
| Overview | |
| Publisher | Elsevier |
| Language | English |
| Article Processing Charges | USD 2800 |
| Publication Time | 10 |
| Editorial Review Process | Blind peer review |
| General Details | |
| Language | English |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| License type | CC BY, CC BY-NC-ND |
| OA statement | Visit website |
View less
Planning to publish in Advances in Cancer Biology - Metastasis ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Advances in Cancer Biology - Metastasis
Repurposing statins in combination therapy for effective ablation of metastatic breast cancer
- 1 Jul 2026
- Advances in Cancer Biology - Metastasis
Alcohol-induced extracellular vesicle signatures: Exploring liquid biopsy biomarkers for early cancer detection and prognosis
- 1 Jul 2026
- Advances in Cancer Biology - Metastasis
Mathematical modeling of breast cancer: Analyzing immune-chemotherapy interactions and sensitivity to key parameters
- 1 Jul 2026
- Advances in Cancer Biology - Metastasis
Histone demethylase KDM6B inhibitor GSK-J4 sensitizes glioma cells to tyrosine kinase inhibitor anlotinib in vitro by reducing PDGFRA expression
- 1 Jul 2026
- Advances in Cancer Biology - Metastasis
The roles of cancer stem cell (CSC)-derived exosomal non-coding RNAs in cancer progression
- 1 Jul 2026
- Advances in Cancer Biology - Metastasis
MicroRNA 146a suppresses tumor progression and enhances therapeutic sensitivity by targeting the EGFR pathway in BRCA1-associated basal-like breast cancers
- 1 Jul 2026
- Advances in Cancer Biology - Metastasis
Repurposing statins in combination therapy for effective ablation of metastatic breast cancer
- 1 Jul 2026
- Advances in Cancer Biology - Metastasis
Alcohol-induced extracellular vesicle signatures: Exploring liquid biopsy biomarkers for early cancer detection and prognosis
- 1 Jul 2026
- Advances in Cancer Biology - Metastasis
Mathematical modeling of breast cancer: Analyzing immune-chemotherapy interactions and sensitivity to key parameters
- 1 Jul 2026
- Advances in Cancer Biology - Metastasis
Histone demethylase KDM6B inhibitor GSK-J4 sensitizes glioma cells to tyrosine kinase inhibitor anlotinib in vitro by reducing PDGFRA expression
- 1 Jul 2026
- Advances in Cancer Biology - Metastasis
The roles of cancer stem cell (CSC)-derived exosomal non-coding RNAs in cancer progression
- 1 Jul 2026
- Advances in Cancer Biology - Metastasis
MicroRNA 146a suppresses tumor progression and enhances therapeutic sensitivity by targeting the EGFR pathway in BRCA1-associated basal-like breast cancers
- 1 Jul 2026
- Advances in Cancer Biology - Metastasis
FAQs on Advances in Cancer Biology - Metastasis
How many articles did Advances in Cancer Biology - Metastasis publish last year? 
Who is the publisher of Advances in Cancer Biology - Metastasis?
